David-Bejker-CEO Affibody

Tue, Jan 20, 2026 10:31 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Affibody Accelerates Phase 1 Study with ABY-271 Following Initial Patient Data Tue, Dec 16, 2025 08:00 CET